In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial of its experimental drug CagriSema — a combination of semaglutide and a medicine called cagrilintide. People on CagriSema lost about 23% of their body weight in a 68-week study, outperforming both drugs when taken alone.

Genevieve Roberts thought weight-loss drugs were a miracle – until excruciating side-effects sent her straight back to a traditional approach

Research tells us that eating enough protein and staying physically active can be helpful in reducing the amount of non-fat mass that is lost when losing weight. One of the best types of exercise is doing resistance training or weight training. This will help to preserve muscle mass, and protein will help us maintain and build muscle.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.

Utah has one of the nation's lowest rates of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic — but their usage is rising. The intrigue: After a flush of celebrity endorsements early on,

Scientists from The University of Texas Health Science Center at San Antonio have discovered a potential new drug that could help people lose weight and avoid liver damage caused by unhealthy diets. This breakthrough could lead to new treatments for obesity and related health problems like diabetes and heart disease.

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating."

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations.

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, providing some relief to investors after another quarter of sales miss for its popular diabetes and weight-loss treatments.